MX2014007689A - Composiciones, sistemas y metodos para promover la recuperacion de neuropatia periferica. - Google Patents

Composiciones, sistemas y metodos para promover la recuperacion de neuropatia periferica.

Info

Publication number
MX2014007689A
MX2014007689A MX2014007689A MX2014007689A MX2014007689A MX 2014007689 A MX2014007689 A MX 2014007689A MX 2014007689 A MX2014007689 A MX 2014007689A MX 2014007689 A MX2014007689 A MX 2014007689A MX 2014007689 A MX2014007689 A MX 2014007689A
Authority
MX
Mexico
Prior art keywords
peripheral neuropathy
compositions
systems
methods
promoting recovery
Prior art date
Application number
MX2014007689A
Other languages
English (en)
Inventor
Michael Chopp
Zhenggang Zhang
Daniel C Morris
Lei Wang
Original Assignee
Ford Henry Health System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ford Henry Health System filed Critical Ford Henry Health System
Publication of MX2014007689A publication Critical patent/MX2014007689A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición compuesta por una cantidad terapéuticamente efectiva de timosina beta 4, secuencias de aminoácidos LKKTET o LKKTNT, y /o cualquier variante conservativa de éstas, o un agente que estimula la producción de cualquiera de estos materiales, o una variante conservativa de éste; para promover la recuperación de neuropatía periférica en un sujeto.
MX2014007689A 2011-12-23 2012-12-21 Composiciones, sistemas y metodos para promover la recuperacion de neuropatia periferica. MX2014007689A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161579951P 2011-12-23 2011-12-23
PCT/US2012/071253 WO2013096773A2 (en) 2011-12-23 2012-12-21 Methods, systems, and compositions for promoting recovery of peripheral neuropathy

Publications (1)

Publication Number Publication Date
MX2014007689A true MX2014007689A (es) 2015-04-13

Family

ID=47561833

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007689A MX2014007689A (es) 2011-12-23 2012-12-21 Composiciones, sistemas y metodos para promover la recuperacion de neuropatia periferica.

Country Status (10)

Country Link
US (1) US9775883B2 (es)
EP (1) EP2793930B1 (es)
JP (1) JP2015506928A (es)
KR (1) KR102060391B1 (es)
AU (1) AU2012358361B2 (es)
CA (1) CA2860302C (es)
ES (1) ES2668815T3 (es)
IL (1) IL233300A (es)
MX (1) MX2014007689A (es)
WO (1) WO2013096773A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014127198A1 (en) * 2013-02-15 2014-08-21 Joslin Diabetes Center Thymic regeneration
CN109865127B (zh) * 2018-11-22 2022-03-04 北京诺思兰德生物技术股份有限公司 经修饰的胸腺素β4在治疗糖尿病周围神经病变方面的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04234325A (ja) 1990-12-27 1992-08-24 Hoechst Japan Ltd 脳および神経障害治療予防剤
DE69924615T3 (de) * 1998-07-30 2011-05-05 The Government Of The United States Of America, Represented By The Department Of Health & Human Services, National Institute Of Health, Office Of Technology Transfer Thymosin beta 4 stimuliert wundheilung
WO2007084544A2 (en) 2006-01-17 2007-07-26 Regenerx Biopharmaceuticals, Inc. Methods of treating or preventing tissue damage caused by increased blood flow
GB2476789A (en) 2009-11-10 2011-07-13 Gl Holdings Inc Bv Use of thymosin for treatment of type 2 diabetes

Also Published As

Publication number Publication date
IL233300A (en) 2017-12-31
CA2860302A1 (en) 2013-06-27
AU2012358361A1 (en) 2014-07-31
IL233300A0 (en) 2014-08-31
WO2013096773A2 (en) 2013-06-27
AU2012358361B2 (en) 2017-09-28
ES2668815T3 (es) 2018-05-22
WO2013096773A3 (en) 2013-11-21
US9775883B2 (en) 2017-10-03
KR102060391B1 (ko) 2019-12-30
CA2860302C (en) 2020-01-21
KR20140108567A (ko) 2014-09-11
US20150224175A1 (en) 2015-08-13
EP2793930A2 (en) 2014-10-29
JP2015506928A (ja) 2015-03-05
EP2793930B1 (en) 2018-02-14

Similar Documents

Publication Publication Date Title
WO2017009843A3 (en) Compositions, articles of manufacture and methods for treating cancer
EA201490809A1 (ru) Способы и композиции для лечения неэффективного эритропоэза
IN2014KN01713A (es)
IN2014KN01716A (es)
IN2014KN01714A (es)
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
ZA201506093B (en) Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
PH12015500301B1 (en) A novel formulation of diclofenac
GB201318761D0 (en) Compounds for the treatment of neuropsychiatric disorders
BR112012033738A2 (pt) método para o tratamento de transtorno bipolar
MX355446B (es) Tratamiento de rinitis.
MX2013010910A (es) Peptidos neuroprotectores.
MX2018008545A (es) Composicion antibacteriana y metodo para tratar infecciones por estafilococos con la composicion antibacteriana.
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.
MX2014007689A (es) Composiciones, sistemas y metodos para promover la recuperacion de neuropatia periferica.
NZ629964A (en) Method for treating inflammation
IN2014DN09297A (es)
IN2013MU03428A (es)
MX359106B (es) Composicion farmaceutica inyectable de dexketoprofeno y tramadol.
IN2014DN07109A (es)
IN2013MU03427A (es)
MX343284B (es) Extracto acuoso de ageratina pichinchensis y uso para el tratamiento de cicatrizacion de heridas.
IN2013MU01155A (es)
IN2013MU01222A (es)
UA101235C2 (ru) Способ получения фармацевтической композиции ранозаживляющего и регенерирующего действия на основе пептидов дермального слоя свиней